Cancer-targeted design of bioresponsive prodrug with enhanced cellular uptake to achieve precise cancer therapy

References

• Anabuki T, Tsukahara M, Okamoto M, et al. (2018). Novel biotin linker with alkyne and amino groups for chemical labelling of a target protein of a bioactive small molecule. Bioorg Med Chem Lett 28:783–6.
   PubMed Web of Science ®Google Scholar
• Binet MT, Doyle CJ, Williamson JE, Schlegel P. (2014). Use of JC-1 to assess mitochondrial membrane potential in sea urchin sperm. J Exp MarBiol Ecol 452:91–100.
   Web of Science ®Google Scholar
• Chamberlain GR, Tulumello DV, Kelley SO. (2013). Targeted delivery of doxorubicin to mitochondria. ACS Chem Biol 8:1389–95.
   PubMed Web of Science ®Google Scholar
• Chugh R, Dunn R, Zalupski MM, et al. (2005). Phase II study of 9-nitro-camptothecin in patients with advanced chordoma or soft tissue sarcoma. J Clin Oncol 23:3597–604.
   PubMed Web of Science ®Google Scholar
• Chung MF, Chia WT, Wan WL, et al. (2015). Controlled release of an anti-inflammatory drug using an ultrasensitive ROS-responsive gas-generating carrier for localized inflammation inhibition. J Am Chem Soc 137:12462–5.
   PubMed Web of Science ®Google Scholar
• Dalton SE, Dittus L, Thomas DA, et al. (2018). Selectively targeting the kinome-conserved lysine of PI3K delta as a general approach to covalent kinase inhibition. J Am Chem Soc 140:932–9.
   PubMed Web of Science ®Google Scholar
• Guo HC, Aleyasin H, Dickinson BC, et al. (2014). Recent advances in hydrogen peroxide imaging for biological applications. Cell Biosci 4:64.
   PubMed Web of Science ®Google Scholar
• Hu XL, Liu GH, Li Y, et al. (2015). Cell-penetrating hyperbranched polyprodrug amphiphiles for synergistic reductive milieu-triggered drug release and enhanced magnetic resonance signals. J Am Chem Soc 137:362–8.
   PubMed Web of Science ®Google Scholar
• Jeon S, Moon JM, Lee ES, et al. (2014). An electroactive biotin-doped polypyrrole substrate that immobilizes and releases EpCAM-positive cancer cells. Angew Chem Int Ed 53:4597–602.
   PubMed Web of Science ®Google Scholar
• Lee JM, Kim JA, Yen TC, et al. (2016a). A rhizavidin monomer with nearly multimeric avidin-like binding stability against biotin conjugates. Angew Chem Int Ed 55:3393–7.
   PubMed Web of Science ®Google Scholar
• Lee MH, Kim EJ, Lee H, et al. (2016b). Liposomal texaphyrin theranostics for metastatic liver cancer. J Am Chem Soc 138:16380–7.
   PubMed Web of Science ®Google Scholar
• Li GF, Zhao MM, Zhao LM. (2016). Well-defined hydroxyethyl starch-10-hydroxy camptothecin super macromolecule conjugate: cytotoxicity, pharmacodynamics research, tissue distribution test and intravenous injection safety assessment. Drug Deliv 23:2860–8.
   PubMed Web of Science ®Google Scholar
• Liang Y, Zhou Y, Deng S, Chen T. (2016). Microwave-assisted syntheses of benzimidazole-containing selenadiazole derivatives that induce cell-cycle arrest and apoptosis in human breast cancer cells by activation of the ROS/AKT pathway. Chem Med Chem 11:2339–46.
   Web of Science ®Google Scholar
• Liang YW, Zheng JS, Li XL, et al. (2014). Selenadiazole derivatives as potent thioredoxin reductase inhibitors that enhance the radiosensitivity of cancer cells. Eur J Med Chem 84:335–42.
   PubMed Web of Science ®Google Scholar
• Lin CC, Zhang X, Chen HB, et al. (2018). Dual-ligand modified liposomes provide effective local targeted delivery of lung-cancer drug by antibody and tumor lineage-homing cell-penetrating peptide. Drug Deliv 25:256–66.
   PubMed Web of Science ®Google Scholar
• Liu F, Dawadi S, Maize KM, et al. (2017a). Structure-based optimization of pyridoxal 5'-phosphate-dependent transaminase enzyme (BioA) inhibitors that target biotin biosynthesis in Mycobacterium tuberculosis. J Med Chem 60:5507–20.
   PubMed Web of Science ®Google Scholar
• Liu QC, Ou CW, Ren CH, et al. (2012). A releasable disulfide carbonate linker for molecular hydrogelations. New J Chem 36:1556–9.
   Web of Science ®Google Scholar
• Liu T, Zeng LL, Jiang WT, et al. (2015). Rational design of cancer-targeted selenium nanoparticles to antagonize multidrug resistance in cancer cells. Nanomed Nanotechnol Biol Med 11:947–58.
   PubMed Web of Science ®Google Scholar
• Liu WQ, Samanta SK, Smith BD, Isaacs L. (2017b). Synthetic mimics of biotin/(strept)avidin. Chem Soc Rev 46:2391–403.
   PubMed Web of Science ®Google Scholar
• Lohmueller JJ, Ham JD, Kvorjak M, Finn OJ. (2018). mSA2 affinity-enhanced biotin-binding CAR T cells for universal tumor targeting. Oncoimmunology 7:e1368604.
   Web of Science ®Google Scholar
• Ma B, He LZ, You YY, et al. (2018). Controlled synthesis and size effects of multifunctional mesoporous silica nanosystem for precise cancer therapy. Drug Deliv 25:293–306.
   PubMed Web of Science ®Google Scholar
• Martin A, Byrne A, Burke CS, et al. (2014). Peptide-bridged dinuclear Ru(II) complex for mitochondrial targeted monitoring of dynamic changes to oxygen concentration and ROS generation in live mammalian cells. J Am Chem Soc 136:15300–9.
   PubMed Web of Science ®Google Scholar
• Mehmood S, Marcoux J, Gault J, et al. (2016). Mass spectrometry captures off-target drug binding and provides mechanistic insights into the human metalloprotease ZMPSTE24. Nature Chem 8:1152–8.
   PubMed Web of Science ®Google Scholar
• Numbenjapon T, Wang J, Colcher D, et al. (2009). Preclinical results of camptothecin-polymer conjugate (IT-101) in multiple human lymphoma xenograft models. Clin Cancer Res 15:4365–73.
   PubMed Web of Science ®Google Scholar
• Renoux B, Raes F, Legigan T, et al. (2017). Targeting the tumour microenvironment with an enzyme-responsive drug delivery system for the efficient therapy of breast and pancreatic cancers. Chem Sci 8:3427–33.
   PubMed Web of Science ®Google Scholar
• Schmidt RC, Healy KE. (2013). Effect of avidin-like proteins and biotin modification on mesenchymal stem cell adhesion. Biomaterials 34:3758–62.
   PubMed Web of Science ®Google Scholar
• Shetty D, Khedkar JK, Park KM, Kim K. (2015). Can we beat the biotin-avidin pair?: cucurbit[7]uril-based ultrahigh affinity host-guest complexes and their applications. Chem Soc Rev 44:8747–61.
   PubMed Web of Science ®Google Scholar
• Shimodaira S, Asano Y, Arai K, Iwaoka M. (2017). Selenoglutathione diselenide: unique redox reactions in the GPx-like catalytic cycle and repairing of disulfide bonds in scrambled protein. Biochemistry 56:5644–53.
   PubMed Web of Science ®Google Scholar
• Song ZH, Liu T, Chen TF. (2018). Overcoming blood-brain barrier by HER2-targeted nanosystem to suppress glioblastoma cell migration, invasion and tumor growth. J Mater Chem B 6:568–79.
   PubMed Web of Science ®Google Scholar
• Staben LR, Koenig SG, Lehar S, et al. (2016). Targeted drug delivery through the traceless release of tertiary and heteroaryl amines from antibody-drug conjugates. Nat Chem 8:1112–19.
   PubMed Web of Science ®Google Scholar
• Steiner M, Hartmann I, Perrino E, et al. (2013). Spacer length shapes drug release and therapeutic efficacy of traceless disulfide-linked ADCs targeting the tumor neovasculature. Chem Sci 4:297–302.
   Web of Science ®Google Scholar
• Szachniewicz M, Bartneck M, Tacke F, Bansal R. (2017). Targeting liver inflammation using Mincle-targeted liposomes as a novel drug delivery system. Hepatology 66:235a–6a.
   PubMed Web of Science ®Google Scholar
• Tian X, Nguyen M, Foote HP, et al. (2017). CRLX101, a nanoparticle-drug conjugate containing camptothecin, improves rectal cancer chemoradiotherapy by inhibiting DNA repair and HIF1 alpha. Cancer Res 77:112–22.
   PubMed Web of Science ®Google Scholar
• Wang YL, Chen M, Huo TG, et al. (2017). Effects of glycyrrhetinic acid on GSH synthesis induced by realgar in the mouse hippocampus: involvement of system, system, MRP-1, and Nrf2. Mol Neurobiol 54:3102–16.
   PubMed Web of Science ®Google Scholar
• Wang ZM, Martensson L, Nilsson R, et al. (2005). Blood pharmacokinetics of various monoclonal antibodies labeled with a new trifunctional chelating reagent for simultaneous conjugation with 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid and biotin before radiolabeling. Clin Cancer Res 11:7171s–7s.
   PubMed Web of Science ®Google Scholar
• Westermann B. (2010). Mitochondrial fusion and fission in cell life and death. Nat Rev Mol Cell Biol 11:872–84.
   PubMed Web of Science ®Google Scholar
• Wu YP, Chew CY, Li TN, et al. (2018). Target-activated streptavidin-biotin controlled binding probe. Chem Sci 9:770–6.
   PubMed Web of Science ®Google Scholar
• Xie LN, Luo ZD, Zhao ZN, Chen TF. (2017). Anticancer and antiangiogenic iron(II) complexes that target thioredoxin reductase to trigger cancer cell apoptosis. J Med Chem 60:202–14.
   PubMed Web of Science ®Google Scholar
• Yang WS, Sriramaratnam R, Welsch ME, et al. (2014). Regulation of ferroptotic cancer cell death by GPX4. Cell 156:317–31.
   PubMed Web of Science ®Google Scholar
• Yi HQ, Liu LL, Sheng N, et al. (2016). Synergistic therapy of doxorubicin and miR-129-5p with self-cross-linked bioreducible polypeptide nanoparticles reverses multidrug resistance in cancer cells. Biomacromolecules 17:1737–47.
   PubMed Web of Science ®Google Scholar
• Zhang BZ, Cheng GG, Zheng MB, et al. (2018). Targeted delivery of doxorubicin by CSA-binding nanoparticles for choriocarcinoma treatment. Drug Deliv 25:461–71.
   PubMed Web of Science ®Google Scholar
• Zhao HY, Ji B, Chen JG, et al. (2017). Gpx 4 is involved in the proliferation, migration and apoptosis of glioma cells. Pathol Res Pract 213:626–33.
   PubMed Web of Science ®Google Scholar
• Zhao ZN, Gao P, You YY, Chen TF. (2018). Cancer-targeting functionalization of selenium-containing ruthenium conjugate with tumor microenvironment-responsive property to enhance theranostic effects. Chem Eur J 24:3289–98.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Basu S, Laue ED, Seshia AA. (2016). Dynamic monitoring of single cell lysis in an impedance-based microfluidic device. Biomed Microdevices 18:56.
   PubMed Web of Science ®Google Scholar